Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells
- 31 October 2001
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1515 (2), 144-158
- https://doi.org/10.1016/s0005-2736(01)00409-6
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Targeting Folate Receptor with Folate Linked to Extremities of Poly(ethylene glycol)-Grafted Liposomes: In Vitro StudiesBioconjugate Chemistry, 1999
- Cellular Trafficking and Cytotoxicity of Anti-Cd19-Targeted Liposomal Doxorubicin in B Lymphoma CellsJournal of Liposome Research, 1999
- Targeted sterically stabilized liposomal drug deliveryPublished by Elsevier ,1998
- Clinical pharmacology and antitumor efficacy of DOXIL (pegylated liposomal doxorubicin)Published by Elsevier ,1998
- Polyethylene Glycol-Liposomal DoxorubicinDrugs, 1997
- Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol) s conjugated at their distal terminals to monoclonal antibodiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- Development of anti-p185HER2 immunoliposomes for cancer therapy.Proceedings of the National Academy of Sciences, 1995
- Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitroBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardiumThe FASEB Journal, 1992
- pH-Induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contactBiochemistry, 1984